Paxman AB (publ) (STO:PAX)

Market Cap	1.06B -22.8%
Revenue (ttm)	305.02M +20.7%
Net Income	4.77M -81.9%
EPS	0.23 -83.0%
Shares Out	23.27M
PE Ratio	193.43
Forward PE	34.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,338
Average Volume	37,669
Open	45.40
Previous Close	45.40
Day's Range	44.40 - 48.90
52-Week Range	44.20 - 85.80
Beta	0.45
RSI	40.79
Earnings Date	Feb 20, 2026

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 142
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.